60-day Federal Register Notice

Att 2a_0920-0199 60d FRN_10212020.pdf

Import Permit Applications (42 CFR 71.54)

60-day Federal Register Notice

OMB: 0920-0199

Document [pdf]

Download: pdf | pdf

66987

Federal Register / Vol. 85, No. 204 / Wednesday, October 21, 2020 / Notices
• Cognitive laboratory studies, such as
those used to refine questions or
assess usability of a website;
• Qualitative customer satisfaction
surveys (e.g., post-transaction
surveys; opt-out web surveys)

• In-person observation testing (e.g.,
website or software usability tests)

information collection to ensure
compliance with the terms of this
clearance prior to submitting each
collection to OMB. CDC requests
approval for an estimated 3,850 annual
burden hours. There are no costs to
respondents other than their time.

The Agency has established a
manager/managing entity to serve for
this generic clearance and will conduct
an independent review of each

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total burden
(in hours)

Form name

General public ...................................

Online surveys .................................
Focus groups ...................................
In-person surveys .............................
Usability testing ................................
Customer comment cards ................

1,500
800
1,000
1,500
1,000

1
1
1
1
1

30/60
2
30/60
30/60
15/60

750
1,600
500
750
250

Total ...........................................

...........................................................

........................

3,850

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–23247 Filed 10–20–20; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[60Day-21–0199; Docket No. CDC–2020–
0107]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Application for Permit to Import
Biological Agents and Vectors of Human
Disease into the United States,
Application for Permit to Import or
Transport Live Bats, and Application for
Permit to Import Infectious Human
Remains into the United States (OMB
Control No. 0920–0199). The purpose of
this data collection is to support Section
361 of the Public Health Service (PHS)

SUMMARY:

VerDate Sep<11>2014

16:58 Oct 20, 2020

Jkt 253001

Act and to prevent the introduction,
transmission, or spread of
communicable diseases from foreign
countries into the States or possessions,
or from one State or possession into any
other State or possession.
DATES: CDC must receive written
comments on or before December 21,
2020.
You may submit comments,
identified by Docket No. CDC–2020–
0199 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
ADDRESSES:

Centers for Disease Control and
Prevention

khammond on DSKJM1Z7X2PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondents

PO 00000

Frm 00062

Fmt 4703

Sfmt 4703

or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Import regulations for infectious
biological agents, infectious substances,
and vectors (42 CFR 71.54) (OMB
Control No. 0920–0199, Exp. 4/30/

E:\FR\FM\21OCN1.SGM

21OCN1

66988

Federal Register / Vol. 85, No. 204 / Wednesday, October 21, 2020 / Notices

2021)—Revision—Center for
Preparedness and Response (CPR),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Section 361 of the Public Health
Service Act (42 U.S.C. 264), as
amended, authorizes the Secretary of
Health and Human Services to make
and enforce such regulations as are
necessary to prevent the introduction,
transmission, or spread of
communicable diseases from foreign
countries into the States or possessions,
or from one State or possession into any
other State or possession. Part 71 of
Title 42, Code of Federal Regulations
(Foreign Quarantine) sets forth
provisions to prevent the introduction,
transmission, and spread of
communicable disease from foreign
countries into the United States.
Subpart F—Importations—contains
provisions for the importation of
infectious biological agents, infectious
substances, and vectors (42 CFR 71.54);
requiring persons that import these
materials to obtain a permit issued by
the CDC.
The Application for Permit to Import
Biological Agents, Infectious Substances
and Vectors of Human Disease into the
United States form is used by laboratory
facilities, such as those operated by

isolation and containment information.
CDC does not plan to revise this
application.

government agencies, universities, and
research institutions to request a permit
for the importation of biological agents,
infectious substances, or vectors of
human disease. This form currently
requests applicant and sender contact
information; description of material for
importation; facility isolation and
containment information; and personnel
qualifications. CDC plans to revise this
application to:
(1) Remove question 10 ‘‘Will the
permittee be the courier of the imported
biological agent?’’ from Section A since
it is the same question found in section
C, question 1.
(2) Add example to section F,
question 2 for clarity to read,
‘‘Protective Clothing (e.g., laboratory
coat).’’
These revisions will not affect the
burden hours.
The Application for Permit to Import
or Transport Live Bats form is used by
laboratory facilities such as those
operated by government agencies,
universities, research institutions, and
for educational, exhibition, or scientific
purposes to request a permit for the
importation, and any subsequent
distribution after importation, of live
bats. This form currently requests the
applicant and sender contact
information; a description and intended
use of bats to be imported; and facility

The Application for Permit to Import
Infectious Human Remains into the
United States is used by facilities that
will bury/cremate the imported cadaver
and educational facilities to request a
permit for the importation and
subsequent transfers throughout the
U.S. of human remains or body parts
that contains biological agents,
infectious substances, or vectors of
human disease. This form will request
applicant and sender contact
information; facility processing human
remains; cause of death; biosafety and
containment information; and final
destination(s) of imported infectious
human remains. CDC does not plan to
revise this application.
Annualized burden hours were
calculated based on data obtained from
CDC import permit database on the
number of permits issued on annual
basis since 2015, which is 2,000
respondents. The total estimated burden
for the data collection is 1,098. There is
a decrease in burden from 1,355 hours
to 1,098 hours to reflect the
implementation of the Electronic Import
Permit Program portal (eIPP) which has
decreased the time required to enter
information.

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total burden
hours

Form name

Applicants Requesting to Import Biological Agents, Infectious Substances and Vectors.

2,000

30/60

1,000

380

10/60

Applicants Requesting to Import Live
Bats.
Applicants Requesting to Import Infectious Human Remains into the
United States.

Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human
Disease into the United States.
Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human
Disease into the United StatesSubsequent Transfer.
Application for a Permit to Import
Live Bats.
Application for Permit to Import Infectious Human Remains into the
United States.

20/60

100